Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Larimar Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 45 | 54 | +9 |
| Shares | 14.5M | 14.5M | −24.6K (−0.2%) |
| Value | $142.8M | $167.5M | +$24.7M (+17.3%) |
New holders (13)
Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fred Alger Management, LLC | 175,870 | $2.03M | 0.00% |
| BIT Capital GmbH | 94,016 | $1.08M | 0.06% |
| Susquehanna International Group, LLP | 69,817 | $805.0K | 0.00% |
| Asymmetry Capital Management, L.P. | 34,943 | $403.0K | 0.24% |
| Two Sigma Advisers, LP | 32,898 | $379.0K | 0.00% |
| Two Sigma Investments, LP | 30,607 | $353.0K | 0.00% |
| Belvedere Trading LLC | 22,954 | $276.0K | 0.08% |
| HRT Financial LP | 21,174 | $244.0K | 0.00% |
| Dimensional Fund Advisors LP | 15,407 | $178.0K | 0.00% |
| Jane Street Group, LLC | 12,001 | $138.0K | 0.00% |
| Northeast Financial Consultants Inc | 10,105 | $117.0K | 0.01% |
| Group One Trading, L.P. | 1,000 | $12.0K | 0.00% |
| Advisor Group Holdings, Inc. | 29 | $0 | 0.00% |
Sold out (4)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Millennium Management LLC | 257,868 | $2.53M |
| Boothbay Fund Management, LLC | 10,163 | $100.0K |
| First Manhattan Co | 4,000 | $39.0K |
| Acadian Asset Management LLC | 457 | $4.00K |